Skip to content

Do peptides actually do anything?

The evidence is real but modest, and how a peptide is dosed and delivered matters more than which one is named on the label.

SerumTruth Editorial · Updated July 2026 · 5 min read
The short version

Peptides are short chains of amino acids that signal skin cells to behave differently. Copper peptides (GHK-Cu), Matrixyl, and Argireline each have some supporting research, mostly small studies, for the appearance of firmness and fine lines. Expect a gradual, modest improvement over months, not a fast or dramatic one, and know that concentration and formulation matter more than the name on the bottle.

Peptides get marketed like a single miracle category, when really they are a loose family of ingredients with different jobs, different evidence, and very different odds of surviving the trip from the bottle into your skin.

What a peptide is supposed to do

A peptide is a short fragment of protein, small enough to signal a cell rather than build a structure itself. Depending on the sequence, that signal can prompt fibroblasts to behave as though collagen repair is already underway, or it can interrupt the small muscle movements behind an expression line. None of that is one mechanism, which is why lumping every peptide into a single claim misses the point.

The main players

  • Copper peptides (GHK-Cu) occur naturally in the body and have the longest research history of the group, including older wound-healing work. The evidence for the appearance of firmer, smoother skin is reasonably established, though copper at higher concentrations can be a formulation challenge of its own.
  • Matrixyl (palmitoyl pentapeptide) is a signal peptide marketed heavily for the appearance of fine lines. Much of the supporting research comes from the ingredient supplier rather than independent labs, which does not make it false, just less independently confirmed than older actives like retinol.
  • Argireline (acetyl hexapeptide) is sold as a topical stand-in for more invasive line-relaxing treatments. The mechanism is plausible on paper, but independent human trials are limited and small, so treat the more dramatic claims with real skepticism.

How honest is the evidence, really

A meaningful share of peptide research is funded and published by the companies that sell the raw ingredient, with small sample sizes and short trial windows. That is a real conflict of interest, not a reason to dismiss the ingredient outright. It puts peptides in a middle tier, moderate to limited evidence, worth using, but not in the same category of proof as decades of independent retinoid research.

What to actually expect

Used consistently for eight to twelve weeks, a well-formulated peptide serum can support the appearance of smoother texture and softer fine lines. It is a supporting layer, not a replacement for sunscreen or a retinoid, and the change is gradual rather than visible overnight. Anyone promising a dramatic transformation from a peptide serum alone is overselling the ingredient.

Dose and delivery matter more than the name on the bottle

Peptides are large, fragile molecules that can be broken down by the wrong pH, poor packaging, or a formula that cannot get them past the skin surface. A serum can list Matrixyl or a copper peptide complex on the label and still underdeliver if the concentration is too low or the formulation cannot carry it to where it needs to go. Brands rarely disclose peptide percentages. The ingredient name ends up the least useful part of the label, the formulation quality behind it matters more.

More from the journal

Cosmetic information for general education, not medical advice. Underlined terms link to our ingredient dossiers.